Compare PFN & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFN | EIKN |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 699.5M | 731.6M |
| IPO Year | 2004 | N/A |
| Metric | PFN | EIKN |
|---|---|---|
| Price | $6.86 | $11.10 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.60 |
| AVG Volume (30 Days) | ★ 425.4K | 288.6K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.53 | $7.90 |
| 52 Week High | $7.65 | $16.50 |
| Indicator | PFN | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 50.35 |
| Support Level | $6.53 | $10.82 |
| Resistance Level | $7.54 | $12.16 |
| Average True Range (ATR) | 0.08 | 1.21 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 26.53 | 44.40 |
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.